Research on perfluorocarbon nanoparticles carrier in the targeted diagnosis and treatment.
- Author:
Xuemei PENG
1
;
Juanhua XIE
;
Huadong WANG
Author Information
1. Department of Anesthesiology, First Affiliated Hospital, Jinan University, Guangzhou 510632, China. pengxuemeijnu@tom.com
- Publication Type:Journal Article
- MeSH:
Animals;
Biocompatible Materials;
pharmacology;
Chemical Phenomena;
Drug Carriers;
pharmacology;
Drug Delivery Systems;
Fluorocarbons;
pharmacology;
Humans;
Nanoparticles
- From:
Journal of Biomedical Engineering
2012;29(6):1217-1220
- CountryChina
- Language:Chinese
-
Abstract:
The perfluorocarbon (PFC) nanoparticle is a sort of new drug carrier in recent years, and it has lots of unique properties such as chemical stability, favourable biocompatibility, high aerobic capacity, targeting action to tissues or cells and so on. In this paper, we summarize the physico-chemical properties of the PFC nanoparticles. We also show the research progress of the PFC nanoparticles as a kind of drug carrier for targeted therapy of cardiovascular system, nervous system diseases and tumor. Further more, its characteristics of being selectively in target cells, tissues, and rapid release of drugs are expounded. PFC nanoparticles, as drug carriers for targeted diagnosis and treatment, have good prospect and clinical application value.
